Clinical Trial 48621

Evergreen Park, IL 60805


We are currently looking for participants who have a documented diagnosis of Idiopathic Pulmonary Fibrosis (IPF) and are 40 years or older.

The study will be investigating whether a study treatment called CSL312 will be effective over a 14 week treatment period in patients who have IPF.

Qualified Participants Must:

• Have been diagnosed with IPF
• Are 40 years or older

Qualified Participants May Receive:

During the study you will be asked to:

  • Come to on-site clinical visits to receive study treatment (complimentary transportation may be provided if needed)
  • Provide blood samples and urine samples
  • Complete spirometry testing
  • At the end of the study, you will be asked to attend a final follow-up visit over the phone.

  • $150 upon completion of the screening visit
  • $50 upon completion of the subsequent visit
  • Ask your study team about transportation and home health services at no cost to you

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.